Formulary Drug Reviews: Glecaprevir/Pibrentasvir.


Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in… (More)
DOI: 10.1177/0018578717746417


  • Presentations referencing similar topics